For: | Nishimoto A. Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment. World J Gastroenterol 2022; 28(28): 3637-3643 [PMID: 36161054 DOI: 10.3748/wjg.v28.i28.3637] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i28/3637.htm |
Number | Citing Articles |
1 |
Tianqi Xu, Alexey Schulga, Elena Konovalova, Sara S. Rinne, Hongchao Zhang, Olga Vorontsova, Anna Orlova, Sergey M. Deyev, Vladimir Tolmachev, Anzhelika Vorobyeva. Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin–Toxin Fusion in a Pancreatic Cancer Xenograft Model. International Journal of Molecular Sciences 2023; 24(3): 2838 doi: 10.3390/ijms24032838
|
2 |
Jiongjia Cheng, Ting Zhu, Shaoxian Liu, Jiayu Zhou, Xiaofeng Wang, Guangxiang Liu. Prediction of synergistic gemcitabine-based combination treatment through a novel tumor stemness biomarker NANOG in pancreatic cancer. RSC Medicinal Chemistry 2024; 15(11): 3853 doi: 10.1039/D4MD00165F
|
3 |
Jinghui Jin, Juan Nan, Yanpo Si, Xiaohui Chen, Haibo Wang, Xiaowei Wang, Jingwang Huang, Tao Guo. Exploring the therapeutic potential of rabdoternin E in lung cancer treatment: Targeting the ROS/p38 MAPK/JNK signaling pathway. Molecular Medicine Reports 2024; 30(5) doi: 10.3892/mmr.2024.13330
|
4 |
Ri Huang, Hong Du, Liang Cheng, Ning Zhao, Peizhuo Zhang, Fenghua Meng, Zhiyuan Zhong. Targeted Delivery of siRNA-Gemcitabine Oligonucleotide Chimeras for High-Efficacy Synergistic Treatment of Pancreatic Cancer. Chemistry of Materials 2024; 36(24): 11881 doi: 10.1021/acs.chemmater.4c02335
|
5 |
Ning Cheng, Li Wang, Yiping Liu, Bosheng Song, Changsong Ding. HANSynergy: Heterogeneous Graph Attention Network for Drug Synergy Prediction. Journal of Chemical Information and Modeling 2024; 64(10): 4334 doi: 10.1021/acs.jcim.4c00003
|
6 |
Jay Natu, Ganji Purnachandra Nagaraju. Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: Special focus on resistance mechanisms and metronomic therapies. Cancer Letters 2023; 573: 216382 doi: 10.1016/j.canlet.2023.216382
|
7 |
Priti Gupta, Charles F. Hodgman, Claudia Alvarez-Florez, Keri L. Schadler, Melissa M. Markofski, Daniel P. O’Connor, Emily C. LaVoy. Comparison of three exercise interventions with and without gemcitabine treatment on pancreatic tumor growth in mice: No impact on tumor infiltrating lymphocytes. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.1039988
|
8 |
Jun-Hao Huang, Wei Guo, Zhe Liu. Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer. World Journal of Gastroenterology 2023; 29(3): 579-581 doi: 10.3748/wjg.v29.i3.579
|
9 |
Ziying Zhou, Yi Nan, Xiangyang Li, Ping Ma, Yuhua Du, Guoqing Chen, Na Ning, Shicong Huang, Qian Gu, Weiqiang Li, Ling Yuan. Hawthorn with “homology of medicine and food”: a review of anticancer effects and mechanisms. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1384189
|
10 |
Junliang Chen, Zhihao Liu, Zhiyuan Wu, Wenjun Li, Xiaodong Tan. Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1132424
|
11 |
Yanfang Cao, Renwei Xing, Fan Yang, Yang Zhang, Xianfei Zhou. Establishment of a prognostic model for pancreatic cancer based on vesicle-mediated transport protein-related genes. Computer Methods in Biomechanics and Biomedical Engineering 2024; : 1 doi: 10.1080/10255842.2024.2367739
|
12 |
Yugandhar Kothapalli, Tucker A. Lesperance, Ransom A. Jones, Chung K. Chu, Uma S. Singh. Chemical Space of Fluorinated Nucleosides/Nucleotides in Biomedical Research and Anticancer Drug Discovery. Chemistry 2025; 7(1): 7 doi: 10.3390/chemistry7010007
|
13 |
Jianxi Huang, Yu-Ting Chien, Qingxin Mu, Miqin Zhang. An Efficient Fabrication Approach for Multi-Cancer Responsive Chemoimmuno Co-Delivery Nanoparticles. Pharmaceutics 2024; 16(10): 1246 doi: 10.3390/pharmaceutics16101246
|